Literature DB >> 27919744

Co-infections with liver fluke and Helicobacter species: A paradigm change in pathogenesis of opisthorchiasis and cholangiocarcinoma?

Banchob Sripa1, Raksawan Deenonpoe2, Paul J Brindley3.   

Abstract

Infection with the fish-borne liver fluke Opisthorchis viverrini is classified by the International Agency for Research on Cancer as a Group 1 carcinogen: definitely carcinogenic in humans. Cofactors likely contribute to bile duct cancer (cholangiocarcinoma) caused by this infection. Here we review recent findings that address the role of liver fluke associated H. pylori in hepatobiliary disease and malignancy. We hypothesize that co-infection by O. viverrini and the bacillus Helicobacter pylori is central of liver fluke infection associated cholangiocarcinoma.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cholangiocarcinoma; Co-infection; Helicobacter spp.; Hepatobiliary diseases; Liver fluke; Opisthorchis viverrini; Pathogenesis

Mesh：

Year:  2016        PMID： 27919744      PMCID： PMC5457716          DOI： 10.1016/j.parint.2016.11.016

Source DB:  PubMed          Journal:  Parasitol Int        ISSN： 1383-5769            Impact factor:   2.230


  63 in total

1.  Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation.

Authors:  Wongwarut Boonyanugomol; Chariya Chomvarin; Banchob Sripa; Vajarabhongsa Bhudhisawasdi; Narong Khuntikeo; Chariya Hahnvajanawong; Amporn Chamsuwan
Journal:  HPB (Oxford)       Date:  2012-01-10       Impact factor: 3.647

2.  Association of diverse bacterial communities in human bile samples with biliary tract disorders: a survey using culture and polymerase chain reaction-denaturing gradient gel electrophoresis methods.

Authors:  E Tajeddin; S J Sherafat; M R S Majidi; M Alebouyeh; A H M Alizadeh; M R Zali
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-05-18       Impact factor: 3.267

3.  Microbiota studies in the bile duct strongly suggest a role for Helicobacter pylori in extrahepatic cholangiocarcinoma.

Authors:  F Avilés-Jiménez; A Guitron; F Segura-López; A Méndez-Tenorio; S Iwai; A Hernández-Guerrero; J Torres
Journal:  Clin Microbiol Infect       Date:  2015-10-20       Impact factor: 8.067

4.  Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin.

Authors:  Marina Aspholm-Hurtig; Giedrius Dailide; Martina Lahmann; Awdhesh Kalia; Dag Ilver; Niamh Roche; Susanne Vikström; Rolf Sjöström; Sara Lindén; Anna Bäckström; Carina Lundberg; Anna Arnqvist; Jafar Mahdavi; Ulf J Nilsson; Billie Velapatiño; Robert H Gilman; Markus Gerhard; Teresa Alarcon; Manuel López-Brea; Teruko Nakazawa; James G Fox; Pelayo Correa; Maria Gloria Dominguez-Bello; Guillermo I Perez-Perez; Martin J Blaser; Staffan Normark; Ingemar Carlstedt; Stefan Oscarson; Susann Teneberg; Douglas E Berg; Thomas Borén
Journal:  Science       Date:  2004-07-23       Impact factor: 47.728

5.  Infections of Helicobacter spp. in the biliary system are associated with biliary tract cancer: a meta-analysis.

Authors:  Di Zhou; Jian-dong Wang; Ming-zhe Weng; Yong Zhang; Xue-feng Wang; Wei Gong; Zhi-wei Quan
Journal:  Eur J Gastroenterol Hepatol       Date:  2013-04       Impact factor: 2.566

Review 6.  From the stomach to other organs: Helicobacter pylori and the liver.

Authors:  Marek Waluga; Michał Kukla; Michał Żorniak; Agata Bacik; Rafał Kotulski
Journal:  World J Hepatol       Date:  2015-08-28

Review 7.  Extragastric manifestations of Helicobacter pylori infection: Possible role of bacterium in liver and pancreas diseases.

Authors:  Elizabeth Ma Rabelo-Gonçalves; Bruna M Roesler; José Mr Zeitune
Journal:  World J Hepatol       Date:  2015-12-28

8.  Liver carcinoma and liver fluke infection.

Authors:  Y I Kim
Journal:  Arzneimittelforschung       Date:  1984

Review 9.  Cholangiocarcinoma: lessons from Thailand.

Authors:  Banchob Sripa; Chawalit Pairojkul
Journal:  Curr Opin Gastroenterol       Date:  2008-05       Impact factor: 3.287

Review 10.  Pathogenesis, diagnosis, and management of cholangiocarcinoma.

Authors:  Sumera Rizvi; Gregory J Gores
Journal:  Gastroenterology       Date:  2013-10-15       Impact factor: 22.682
View more
  4 in total

1.  Elevated prevalence of Helicobacter species and virulence factors in opisthorchiasis and associated hepatobiliary disease.

Authors:  Raksawan Deenonpoe; Eimorn Mairiang; Pisaln Mairiang; Chawalit Pairojkul; Yaovalux Chamgramol; Gabriel Rinaldi; Alex Loukas; Paul J Brindley; Banchob Sripa
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

Review 2.  Liver Fluke-Associated Biliary Tract Cancer.

Authors:  Piyapan Prueksapanich; Panida Piyachaturawat; Prapimphan Aumpansub; Wiriyaporn Ridtitid; Roongruedee Chaiteerakij; Rungsun Rerknimitr
Journal:  Gut Liver       Date:  2018-05-15       Impact factor: 4.519

Review 3.  Microbes and Cancer: Friends or Faux?

Authors:  Maria Manuel Azevedo; Cidália Pina-Vaz; Fátima Baltazar
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

Review 4.  Helminths and Cancers From the Evolutionary Perspective.

Authors:  Larissa L S Scholte; Marcelo A Pascoal-Xavier; Laila A Nahum
Journal:  Front Med (Lausanne)       Date:  2018-04-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.